Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,396.50
+3.07%
(+71.40) 1D
Apr 28, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLENMARK...
Open
₹2,328.10
High
₹2,427.40
Low
₹2,327.30
Mkt. cap
678.78B
Avg. vol.
565.59K
Volume
1.54M
Dividend
0.16%
Quarterly dividend
₹0.94
Ex dividend date
Oct 3, 2025
P/E ratio
63.53
52-wk high
₹2,427.40
52-wk low
₹1,355.40
EPS
₹37.72
Shares outstanding
0.00
No. of employees
16K
News stories
From sources across the web
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees15.8K
FoundedNov 18, 1977
Headquarters-
SectorPharmaceutical industry
Last report
Feb 1, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
19.21/ (19.20 est.)INR
+0.05%beat
Revenue / Estimate
39.01B/ (38.60B est.)INR
+1.05%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
32.98B
32.64B
60.47B
39.01B
Cost of goods sold
12.61B
10.16B
12.65B
12.95B
Cost of revenue
12.61B
10.16B
12.65B
12.95B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.96B
7.63B
10.86B
8.41B
Operating expense
15.60B
17.98B
25.64B
18.90B
Total operating expenses
28.20B
28.14B
38.29B
31.85B
Operating income
4.77B
4.51B
22.18B
7.15B
Other non operating income
-1.02B
264.42M
2.01B
444.65M
EBT including unusual items
79.74M
955.78M
9.67B
5.34B
EBT excluding unusual items
3.81B
4.19B
23.53B
7.18B
Income tax expense
35.90M
486.05M
3.57B
1.31B
Effective tax rate
45.02%
50.85%
36.90%
24.49%
Other operating expenses
386.24M
9.06B
13.37B
8.94B
Net income
46.50M
468.71M
6.10B
4.03B
Net profit margin
0.14%
1.44%
10.09%
10.34%
Earnings per share
7.21
7.29
-
19.21
Interest and investment income
439.41M
-
-
-
Interest expense
-667.12M
-582.26M
-664.63M
-414.32M
Net interest expenses
-227.71M
-582.26M
-664.63M
-414.32M
Depreciation and amortization charges
1.25B
1.30B
1.41B
1.54B
EBITDA
5.43B
5.72B
23.54B
7.80B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more